CIBC Bancorp USA
HRMY icon

CIBC Bancorp USA’s Harmony Biosciences HRMY Stock Holding History

CIBC Bancorp USA’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$318K Buy
8,100
+2,100
+35% +$81.1K ﹤0.01% 1650
2026
Q2 		$218K Buy
+6,000
New +$189K ﹤0.01% 1726

Other funds holding HRMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

CIBC Bancorp USA's HRMY Position: Q3 2026 in Review

CIBC Bancorp USA increased its Harmony Biosciences (HRMY) stake by 35% in Q3 2026, buying an estimated $81.1K and bringing the position to 8,100 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

CIBC Bancorp USA first reported a position in HRMY in Q2 2026 and has held it in 2 quarters since. 279 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • CIBC Bancorp USA held 8,100 shares of Harmony Biosciences worth $318K as of Q3 2026.
  • CIBC Bancorp USA bought 2,100 Harmony Biosciences shares in Q3 2026, an estimated $81.1K.
  • Harmony Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1650 holding.
  • CIBC Bancorp USA first reported a position in Harmony Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.